Results 161 to 169 of about 2,540 (169)

Effects of Renal Impairment on the Pharmacokinetics, Efficacy, and Safety of Inclisiran: An Analysis of the ORION-7 and ORION-1 Studies

Mayo Clinic Proceedings, 2020
R Scott Wright, Michael G Collins, Robert M Stoekenbroek   +2 more
exaly  

Inclisiran for children: is it worth it?

The Lancet Diabetes & Endocrinology
Lluís, Masana, Daiana, Ibarretxe
openaire   +2 more sources

Safety and efficacy of inclisiran in treating hypercholesterolemia: A systemic review and meta-analysis

Nutrition, Metabolism and Cardiovascular Diseases
Congxin Li
exaly  

Inclisiran/pantoprazole

Reactions Weekly
openaire   +1 more source

Evolocumab/Inclisiran/Tirzepatide

Reactions Weekly
openaire   +1 more source

An “Inclisiran First” Strategy vs Usual Care in Patients With Atherosclerotic Cardiovascular Disease

Journal of the American College of Cardiology
Michael J Koren, Fatima Rodríguez, Cara East   +2 more
exaly  

Inclisiran administration potently and durably lowers LDL-C over an extended-term follow-up: the ORION-8 trial

Cardiovascular Research
Gregory G Schwartz, Anastasia Lesogor, Lawrence A Leiter   +2 more
exaly  

First Report of Inclisiran Utilization for Hypercholesterolemia Treatment in Real-world Clinical Settings in a Middle East Population

Clinical Therapeutics
Raúl D Santos
exaly  

Inclisiran siRNA technology in the management of dyslipidemia: A narrative review of clinical trials

Current Problems in Cardiology
exaly